tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market

BioMark Diagnostics (BUX) Cash flow

Compare
3 Followers

BioMark Diagnostics Cash Flow

TSE:BUX's free cash flow for Q2 2024 was C$-130.64K. For the 2024 fiscal year, TSE:BUX's free cash flow was decreased by C$-67.19K and operating cash flow was C$-130.64K. See a summary of the company’s cash flow.
Cash Flow
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
C$ -982.52KC$ -914.42KC$ -1.20MC$ -455.55KC$ -453.79K
Investing Cash Flow
C$ -4.39KC$ -5.30KC$ -59.20KC$ -3.20KC$ -790.00
Financing Cash Flow
C$ 1.07MC$ 609.05KC$ 768.16KC$ 724.63KC$ 1.05M
End Cash Position
C$ 156.75KC$ 72.04KC$ 382.71KC$ 877.68KC$ 611.80K
Free Cash Flow
C$ -986.91KC$ -919.72KC$ -1.26MC$ -455.55KC$ -454.57K
Currency in CAD

BioMark Diagnostics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis